In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci.
In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci.
复制标题
arylomycin 天然产物抗生素对表皮葡萄球菌和其他凝固酶阴性葡萄球菌的体外活性。
DOI:
10.1128/aac.01459-10
复制
发表时间:
2011
影响因子:
4.9
通讯作者:
Romesberg,FloydE
中科院分区:
文献类型:
--
作者:
Smith,PeterA;Powers,MichaelE;Roberts,TuckerC;Romesberg,FloydE
The arylomycins are a class of natural-product antibiotics that act via the inhibition of type I signal peptidase (SPase), and we have found in diverse bacteria that their activity is limited by the presence of a resistance-conferring Pro residue in SPase that reduces inhibitor binding. We have also demonstrated thatStaphylococcus epidermidis, which lacks this Pro residue, is extremely susceptible to the arylomycins. Here, to further explore the potential utility of the arylomycins, we report an analysis of the activity of a synthetic arylomycin derivative, arylomycin C16, against clinical isolates ofS. epidermidisand other coagulase-negative staphylococci (CoNS) from distinct geographical locations. Against many important species of CoNS, includingS. epidermidis,S. haemolyticus,S. lugdunensis, andS. hominis, we find that arylomycin C16exhibits activity equal to or greater than that of vancomycin, the antibiotic most commonly used to treat CoNS infections. While the susceptibility was generally correlated with the absence of the previously identified Pro residue, several cases were identified where additional factors also appear to contribute.